EVERSANA
EVERSANA is a global life sciences commercialization services company that provides consulting, market access, patient services, field solutions, and outsourced commercial operations to pharmaceutical, biotech, and medical device companies. It supports drug launches and in-market products with services spanning pricing and market access, patient support, distribution, and data-driven marketing and sales execution. The company generates revenue through fee-for-service engagements, outsourced commercial partnerships, and platform-based service contracts with life sciences manufacturers.
- IT Consulting & Implementation
- Revenue
- $1.2B
- Employees
- 7,000
- Founded
- 2018
- Headquarters
- Milwaukee, United States of America
What 100 Arbolus experts think of EVERSANA
NPS distribution skews positive, with over 42% scoring 9 or 10 (promoters), and most remaining scores in the 7-8 range (passives). Only a small minority (under 8%) fall below 6 (potential detractors). Renewal intent is strong among high spenders and experienced implementations, with the majority indicating intent to renew or 'not sure'. Stickiness is high, as over 65% of respondents are in the 'More than 1 year' implementation stage. Overall themes include perceived long-term value, robust support, and effective enablement for complex pharmaceutical operations.Overall Customer Sentiment: Positive
Who reviewed EVERSANA
- C-Suite 67% (67)
- Director 27% (27)
- Manager 6% (6)
Employer names and spend open once the report publishes.
Tell us when the EVERSANA report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
18 Net Promoter Score, from 100 scored reviews- Promoters 38
- Passives 42
- Detractors 20
Cumulative NPS by month
+0 over 6 months- May 8
- Jun 8
- Jul 8
- Aug 8
- Sep 8
- Oct 8
Net Promoter Score across 4 reviews, accumulated up to each month. Category median 32 across 4 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 40%Plan to renew, by seniority
- 44% 45 answers
- 28% 18 answers
- 50% 4 answers
- 8.4/10 Average score from customers who will renew
- 7.3/10 Average score from undecided customers
- 8.5/10 Average score from customers not renewing
Top alternatives
Most weighed by EVERSANA customersFor people who use EVERSANA
Do you use EVERSANA at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 100 customers of EVERSANA have already contributed
Takes a few minutes. Your identity stays anonymous.